Alsavaf Mohammad Bilal, Jawad Basit, Salem Eman H, Mongkolkul Kittichai, Limbach Abberly Lott, Prevedello Daniel M, Carrau Ricardo
Department of Otolaryngology-Head and Neck Surgery, Wexner Medical Center at The Ohio State University, Columbus, Ohio, USA,
Department of Neurological Surgery, Wexner Medical Center at The Ohio State University, Columbus, Ohio, USA,
ORL J Otorhinolaryngol Relat Spec. 2024;86(5-6):211-216. doi: 10.1159/000541170. Epub 2024 Oct 9.
Olfactory carcinoma (OC) is a rare tumor that is often misdiagnosed as olfactory neuroblastoma (ONB). Due to its rarity, there is no established standard treatment for OC, and there have been no reports of successful long-term follow-up treatment yet.
Two male patients, aged 54 and 48 years, presented with similar symptoms of nasal obstruction, anosmia, facial swelling, and epistaxis. Imaging in both cases revealed large, locally advanced sinonasal neoplasms. Initial biopsies were concerning for ONB; however, final pathological analyses confirmed high-grade OC. Treatment comprised induction chemotherapy, extensive skull base tumor resection, adjuvant chemoradiotherapy, and reconstructive surgery in both cases. The 54-year-old remains disease-free at 7 years, while the 48-year-old demonstrates no evidence of disease at 8 months.
Accurate diagnostic differentiation is imperative to optimize a treatment approach. Although outcomes with OC tend to be worse than those of ONB, effective control can be achieved with judicious concurrent use of neoadjuvant, surgery, and adjuvant treatments. Ongoing surveillance, biobanking, and genomic analysis are crucial to gain a better understanding of this complex disease.
嗅神经母细胞瘤(OC)是一种罕见肿瘤,常被误诊为嗅神经母细胞瘤(ONB)。由于其罕见性,OC尚无既定的标准治疗方法,目前也尚无成功的长期随访治疗报告。
两名男性患者,年龄分别为54岁和48岁,表现出相似的鼻塞、嗅觉丧失、面部肿胀和鼻出血症状。两例患者的影像学检查均显示鼻窦有巨大的局部晚期肿瘤。最初的活检结果提示为ONB;然而,最终的病理分析确诊为高级别OC。两例患者的治疗均包括诱导化疗、广泛的颅底肿瘤切除术、辅助放化疗和重建手术。54岁的患者7年无病生存,而48岁的患者8个月时未发现疾病迹象。
准确的诊断鉴别对于优化治疗方案至关重要。尽管OC的预后往往比ONB差,但通过明智地联合使用新辅助治疗、手术和辅助治疗,可以实现有效的控制。持续的监测、生物样本库和基因组分析对于更好地了解这种复杂疾病至关重要。